123 results on '"Treat-Jacobson D"'
Search Results
2. Cardiovascular health: The importance of measuring patient-reported health status
- Author
-
Rumsfeld, J. S., Alexander, K. P., Goff, D. C., Graham, M. M., Ho, P. M., Masoudi, F. A., Moser, D. K., Roger, V. L., Slaughter, M. S., Smolderen, K.G.E., Spertus, J. A., Sullivan, M. D., Treat-jacobson, D., Zerwic, J. J., and Medical and Clinical Psychology
- Subjects
human activities - Abstract
A scientific statement from the American Heart Association Keywords: cardiovascular diseases; health care evaluation mechanisms; health status; health surveys; patients
- Published
- 2013
3. Challenges of Implementing a Feasibility Study of Acupuncture in Acute and Critical Care Settings
- Author
-
Lindquist, R., primary, Sendelbach, S., additional, Windenburg, D. C., additional, VanWormer, A., additional, Treat-Jacobson, D., additional, and Chose, D., additional
- Published
- 2008
- Full Text
- View/download PDF
4. Peripheral arterial disease detection, awareness, and treatment in primary care. The peripheral arterial disease awareness, risk, and treatment: new resources for survival (Partners) program investigators
- Author
-
Hirsh, A.T, primary, Criqui, M.H, additional, and Treat-Jacobson, D, additional
- Published
- 2002
- Full Text
- View/download PDF
5. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care
- Author
-
Hirsch, A.T., primary, Halverson, S.L., additional, Treat-Jacobson, D., additional, Hotvedt, P.S., additional, Lunzer, M.M., additional, Krook, S., additional, Rajala, S., additional, and Hunninghake, D.B., additional
- Published
- 2001
- Full Text
- View/download PDF
6. Peer review of nursing research proposals
- Author
-
Lindquist, RD, primary, Tracy, MF, additional, and Treat-Jacobson, D, additional
- Published
- 1995
- Full Text
- View/download PDF
7. Optical Flow, Spatial Orientation, and the Control of Posture in the Elderly
- Author
-
Wade, M. G., primary, Lindquist, R., additional, Taylor, J. R., additional, and Treat-Jacobson, D., additional
- Published
- 1995
- Full Text
- View/download PDF
8. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.
- Author
-
Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenburg NC, Thum CC, Goldberg S, Jaff MR, Steffes MW, Comerota AJ, Ehrman J, Treat-Jacobson D, Walsh ME, Collins T, and Badenhop DT
- Published
- 2012
- Full Text
- View/download PDF
9. Correlates of caregiver burden after coronary artery bypass surgery.
- Author
-
Halm MA, Treat-Jacobson D, Lindquist R, and Savik K
- Published
- 2006
- Full Text
- View/download PDF
10. Peripheral arterial disease rehabilitation: a review.
- Author
-
Falcone RA, Hirsch AT, Regensteiner JG, Treat-Jacobson D, Williams MA, Hiatt WR, and Stewart KJ
- Published
- 2003
11. A patient-derived perspective of health-related quality of life with peripheral arterial disease.
- Author
-
Treat-Jacobson D, Halverson SL, Ratchford A, Regensteiner JG, Lindquist R, and Hirsch AT
- Published
- 2002
- Full Text
- View/download PDF
12. Review: exercise programmes increase walking times in patients with intermittent claudication.
- Author
-
Regensteiner JG and Treat-Jacobson D
- Abstract
QUESTION: In patients with intermittent claudication (leg pain on walking), do exercise programmes increase walking times?Data sourcesRandomised controlled trials were identified by using Medline, EMBASE/Excerpta Medica, handsearches of journals, bibliographies of reviews and identified trials, and contact with principal investigators of trials. The search strategy produced by the Cochrane Review Group on Peripheral Vascular Diseases was used.Study selectionTrials were included if exercise programmes were compared with control or medical or surgical treatment; participants had self reported or clinically diagnosed intermittent claudication caused by atherosclerotic disease; the exercise programme included any form of leg physical activity (eg, walking or running); and outcomes were provided (treadmill walking distance, time to onset of pain, maximal walking distance, mortality, cardiovascular events, disease progression, indirect tests of disease such as ankle pressure measurements, and subjective measures such as symptom progression).Data extractionData were extracted on study quality, exercise and control programmes including duration and intensity, patient numbers and characteristics, and outcomes including how they were measured.Main results10 trials (involving approximately 250 patients) met the inclusion and quality criteria. 3 trials compared exercise with placebo tablets, 3 trials used normal activity as the control programme, 2 trials compared exercise with drugs (antiplatelet agents and pentoxifylline), and 2 compared exercise with arterial reconstruction surgery or angioplasty. All programmes recommended >/= 2 sessions of exercise per week. Duration of the programmes was 3-12 months, and follow up ranged from 12 weeks to 15 months. Exercise increased walking times compared with usual care or placebo, angioplasty, and antiplatelet therapy. Pentoxifylline was better than exercise for walking times in 1 small trial, and no difference was shown between exercise and surgery (table).ConclusionExercise programmes for patients with intermittent claudication generally improve walking times. [Original article accession number: 2001018391 (research, systematic review, tables/charts)] [ABSTRACT FROM AUTHOR]
- Published
- 2001
13. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease) Developed in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition Endorsed by the American Academy of Podiatric Practice Management.
- Author
-
Olin JW, Allie DE, Belkin M, Bonow RO, Casey DE Jr, Creager MA, Gerber TC, Hirsch AT, Jaff MR, Kaufman JA, Lewis CA, Martin ET, Martin LG, Sheehan P, Stewart KJ, Treat-Jacobson D, White CJ, and Zheng ZJ
- Published
- 2010
- Full Text
- View/download PDF
14. Home-Based Exercise and Patient-Reported Outcome Measures in Peripheral Artery Disease: The LITE Randomized Clinical Trial.
- Author
-
Whipple MO, Xu S, Zhang D, Guralnik J, Spring B, Tian L, Treat-Jacobson D, Zhao L, Criqui MH, and McDermott MM
- Abstract
In patients with peripheral artery disease (PAD), we evaluated the effects of 12 months of walking exercise at a pace inducing ischemic leg symptoms (high intensity) on the attainment of meaningful improvement in patient-reported outcome measures (PROMs) and 6-minute walk, compared to walking exercise at a comfortable pace (low intensity) and a nonexercise control. Participants completed the 6-minute walk test (6MWT) to evaluate objective walking ability. PROMs included the Walking Impairment Questionnaire (WIQ) distance and speed scores (range 0 to 100, 100-best, minimal clinically important difference (MCID) = 15 and 11, respectively). 240 participants (61.7% Black, 48.3% female) participated. High intensity exercise increased 6MWT compared to control (+44.8 meters (95% CI:21.7,68.0) and compared to low-intensity exercise (+37.6 meters [95%CI:18.6,56.5]). Low intensity exercise had no significant benefit compared to control (+7.3 meters [95% CI:-16.3,30.9]). High intensity significantly increased attainment of the MCID for the 6MWT compared to low intensity (OR:2.43 [95% CI:1.35,4.38]) and compared to control (OR:5.22 [95% CI:2.32,11.76]). Compared to control, high intensity exercise significantly increased the odds of attaining an MCID for the WIQ distance score (OR:2.30 [95% CI:1.05,5.04]) and WIQ speed score (OR:2.94 [95% CI:1.27,6.83]). Compared to low intensity, high intensity did not significantly increase the odds of attaining an MCID for the WIQ distance (OR:0.93 [95% CI:0.53,1.66]) or the WIQ speed score (OR:1.31 [95% CI:0.71,2.43]). In conclusion, in people with PAD, high intensity walking exercise increased the odds of meaningful improvement in PROMs compared to control, but not compared to low-intensity exercise. Despite this, high intensity exercise improved 6MWT more than the low intensity exercise and nonexercise control groups (NCT02538900)., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mary M. McDermott reports financial support was provided by National Institutes of Health. Mary O. Whipple reports financial support was provided by National Institutes of Health. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2025 Elsevier Inc. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
15. Impact of chemotherapy-induced peripheral neuropathy on physical function in pediatric cancer survivors: a systematic review.
- Author
-
Tanner LR, Demers C, Schorr EN, Rosenberg NS, Hooke MC, Turcotte LM, and Treat-Jacobson D
- Abstract
Purpose: The majority of children, adolescents, and young adults treated with neurotoxic chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN). This side effect can cause numbness and tingling, distal weakness, and autonomic symptoms. These symptoms can lead to impaired physical function and interrupt the development of a child's motor skills. This systematic review provides an essential overview of the relationship between CIPN and physical function impairments, activity limitations, and participation restrictions in children, adolescents, and young adults with cancer., Methods: Following PRISMA guidelines, a search was conducted using the MEDLINE and CINAHL databases between 2013 and March 2024. The quality of each study was assessed using the Joanna Briggs Critical Appraisal Tools. A total of 14 studies were included., Results: This critical review demonstrated significant relationships between CIPN and measures of manual dexterity, gait, balance, motor proficiency, and health-related quality of life. These relationships were observed during treatment and persisted in many survivors years after completing treatment. Higher-level skills such as running speed, standing on one leg, and gait quality over time were more likely to be impacted than basic mobility., Conclusion: CIPN impacts multiple components of physical function and health-related quality of life in survivors of pediatric cancer. In addition to pharmacological and non-pharmacological interventions targeted at these limitations, greater understanding is needed regarding the longitudinal course of these findings with comprehensive assessments sensitive to higher-level physical function., Implications for Cancer Survivors: Assessment of CIPN and physical function for survivors treated with neurotoxic agents is critical to guiding supportive care interventions aimed at improving cancer survivorship., Competing Interests: Declarations. Conflict of interest: LRT is the CEO/Founder of a digital health company., (© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2025
- Full Text
- View/download PDF
16. Symptom Descriptors in Individuals Living With Undiagnosed Lower Extremity Peripheral Artery Disease.
- Author
-
Brown RJL, Treat-Jacobson D, Schorr E, Lindquist R, Pruinelli L, and Wolfson J
- Subjects
- Humans, Male, Female, Aged, Middle Aged, Intermittent Claudication diagnosis, Intermittent Claudication physiopathology, Walking physiology, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease physiopathology, Ankle Brachial Index methods, Lower Extremity physiopathology
- Abstract
Objective: Most individuals with lower extremity peripheral artery disease (PAD) experience symptoms other than claudication and live with undiagnosed PAD yet no tools exist to detect atypical PAD symptoms. The purpose of this study was to identify discriminating PAD symptom descriptors from a community-based sample of patients with no current diagnosis of PAD., Methods: Symptoms descriptors were obtained in a sample of 22 participants with persistent lower extremity symptoms pre/post exercise. An ankle brachial index with exercise was used to classify participants as "PAD" or "No PAD.", Results: Thirteen (59%) participants had a positive ankle brachial index (<0.9, ≥20% drop postexercise, or 30 mmHg drop postexercise). Symptoms do not disappear while walking, trouble keeping up with friends/family, positive response to pain or discomfort while sitting, and pain outside of the calves and thighs were associated with a positive ankle brachial index., Conclusion: Atypical symptoms were common among study participants. Symptoms while sitting and symptoms outside of the calf and thigh were negatively associated with a positive ankle brachial index. More precise descriptions of symptom characteristics are needed to improve PAD symptom recognition., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
17. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
- Author
-
Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Gutiérrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, and Wilkins LR
- Subjects
- Humans, United States, Cardiology standards, Societies, Medical standards, Peripheral Arterial Disease therapy, Peripheral Arterial Disease diagnosis, Lower Extremity blood supply, American Heart Association
- Abstract
Aim: The "2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease" provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia)., Methods: A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate., Structure: Recommendations from the "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed., (Copyright © 2024 American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
18. Uptake and outcomes of supervised exercise therapy for peripheral artery disease: The importance of vascular medicine specialists at a large midwestern health care system during the first 5 years of CMS reimbursement.
- Author
-
Whipple MO, Burt MA, Pergolski AL, McArthur P, Treat-Jacobson D, and Salisbury DL
- Subjects
- Humans, Aged, United States, Centers for Medicare and Medicaid Services, U.S., Quality of Life, Retrospective Studies, Medicare, Exercise Therapy, Delivery of Health Care, Walking, Intermittent Claudication, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease therapy
- Abstract
Background: Supervised exercise therapy (SET) is the cornerstone of medical therapy for symptomatic peripheral artery disease (PAD). Despite the efficacy of SET, initial reports following the 2017 Centers for Medicare and Medicaid Services (CMS) reimbursement decision indicate low SET uptake, referral, and completion. Vascular medicine specialists are key to the success of such programs. We examined rates of SET referral, completion, and outcomes in a health system with a robust SET program during the first 5 years of CMS reimbursement., Methods: A retrospective chart review of patients with PAD referred to SET between October 1, 2017 and December 31, 2022 was conducted. Patient demographic and medical characteristics, SET indication, referring provider specialty, SET participation (e.g., exercise modality, number of sessions, treadmill prescription), and outcomes were abstracted. Descriptive statistics, t -tests, and multiple linear regression were used to examine the sample, evaluate outcomes, and explore outcomes by relevant covariates (i.e., age, sex, referring provider specialty)., Results: Of 5320 patients with PAD, N = 773 were referred to SET; N = 415 enrolled and were included in the present study. Vascular medicine and vascular surgery specialists were the two primary sources of referrals (30.6% and 51.6%, respectively). A total of 207 patients (49.9%) completed SET. Statistically significant and clinically meaningful improvements were observed in all outcomes., Conclusion: SET referral and completion rates are low in the 5 years following CMS reimbursement, despite the advocacy of vascular medicine specialists. SET is effective in improving patient functional capacity and quality of life. Additional efforts are needed to increase both SET availability and referrals as part of comprehensive treatment of PAD., Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
19. Post-surgical complications of a Shamblin Type II carotid body tumor, a case study.
- Author
-
Gowans C and Treat-Jacobson D
- Subjects
- Humans, Vascular Surgical Procedures, Treatment Outcome, Retrospective Studies, Carotid Body Tumor surgery, Carotid Body Tumor complications, Carotid Body Tumor pathology
- Published
- 2023
- Full Text
- View/download PDF
20. Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials.
- Author
-
Thangada ND, Xu S, Tian L, Zhao L, Criqui MH, Ferrucci L, Rejeski WJ, Leeuwenburgh C, Manini T, Spring B, Treat-Jacobson D, Forman DE, Bazzano L, Guralnik J, Sufit R, Polonsky T, Kibbe MR, and McDermott MM
- Subjects
- Humans, Randomized Controlled Trials as Topic, Walking, Exercise Therapy methods, Hospitalization, Intermittent Claudication, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease therapy
- Abstract
Competing Interests: Declaration of conflicting interestsDr McDermott reported receiving research funding from Regeneron and Helixmith and other research support from Helixmith, ArtAssist, ChromaDex, ReserveAge, Mars Company, and personal fees from Cambrian BioPharma. Dr Spring reported receiving research funding from Actigraph scientific advisory board. The other authors reported no disclosures.
- Published
- 2023
- Full Text
- View/download PDF
21. Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial.
- Author
-
Whipple MO, Pfammatter AF, Spring B, Rejeski WJ, Treat-Jacobson D, Domanchuk KJ, Dressler EV, Ferrucci L, Gildea L, Guralnik JM, Harvin L, Leeuwenburgh C, Polonsky TS, Reynolds E, Stowe CL, Sufit R, Van Horn L, Walkup MP, Ambrosius WT, and McDermott MM
- Subjects
- Humans, Research Design, Exercise Therapy, Walking, Follow-Up Studies, Male, Female, Middle Aged, Obesity complications, Obesity therapy, Peripheral Arterial Disease complications, Peripheral Arterial Disease therapy, Weight Reduction Programs methods
- Abstract
Background Overweight and obesity are associated with adverse functional outcomes in people with peripheral artery disease (PAD). The effects of weight loss in people with overweight/obesity and PAD are unknown. Methods The PROVE (Promote Weight Loss in Obese PAD Patients to Prevent Mobility Loss) Trial is a multicentered randomized clinical trial with the primary aim of testing whether a behavioral intervention designed to help participants with PAD lose weight and walk for exercise improves 6-minute walk distance at 12-month follow-up, compared with walking exercise alone. A total of 212 participants with PAD and body mass index ≥25 kg/m
2 will be randomized. Interventions are delivered using a Group Mediated Cognitive Behavioral intervention model, a smartphone application, and individual telephone coaching. The primary outcome is 12-month change in 6-minute walk distance. Secondary outcomes include total minutes of walking exercise/wk at 12-month follow-up and 12-month change in accelerometer-measured physical activity, the Walking Impairment Questionnaire distance score, and the Patient-Reported Outcomes Measurement Information System mobility questionnaire. Tertiary outcomes include 12-month changes in perceived exertional effort at the end of the 6-minute walk, diet quality, and the Short Physical Performance Battery. Exploratory outcomes include changes in gastrocnemius muscle biopsy measures of mitochondrial cytochrome C oxidase activity, mitochondrial biogenesis, capillary density, and inflammatory markers. Conclusions The PROVE randomized clinical trial will evaluate the effects of exercise with an intervention of coaching and a smartphone application designed to achieve weight loss, compared with exercise alone, on walking performance in people with PAD and overweight/obesity. Results will inform optimal treatment for the growing number of patients with PAD who have overweight/obesity. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT04228978.- Published
- 2023
- Full Text
- View/download PDF
22. Clinical Effectiveness of a Supervised Exercise Therapy Program for Treatment of Peripheral Artery Disease: A Translational Study.
- Author
-
Salisbury DL, Brown R, Elgersma K, Larson K, and Treat-Jacobson D
- Subjects
- Humans, Female, Aged, United States, Male, Prospective Studies, Medicare, Exercise Therapy, Treatment Outcome, Walking, Intermittent Claudication, Quality of Life, Peripheral Arterial Disease therapy
- Abstract
Purpose: National guidelines for the treatment and management of symptomatic peripheral artery disease (PAD) recommend supervised exercise therapy (SET) as a first line of therapy. However, it is unknown how these expert opinion-based SET guidelines work in clinical practice as SET programs become established following the 2017 Centers for Medicare & Medicaid Services coverage announcement. The purpose of this prospective, nonrandomized translational study was to evaluate the clinical effectiveness of a SET program and specifically walking exercise modalities that did not incorporate a treadmill (TM)., Methods: Participants enrolled in a 12-wk SET program housed in four rural Midwest cardiac rehabilitation settings and were prescribed an exercise program by an exercise physiologist or nurse based on current SET guidelines. Groups included TM walking, total body recumbent stepping (TBRS), TM walking + TBRS, and multimodal. Pre- and post-tests of walking capacity, physical function, and quality of life were administered., Results: The sample (n = 93) was all White, with 55% female representation, age of 73.7 ± 9.0 yr, and mild-moderate PAD (ankle-brachial index = 0.71 ± 0.19). Collectively, SET significantly improved the 6-min walk test (32.1 ± 6.6 m; P < .01). Within-group changes in the 6-min walk test were seen for all groups except the multimodal group; there were no significant between-group differences in change scores ( P = .30). No significant between-group changes were seen for the TM walking, TBRS, and TM walking + TBRS groups for physical function measures., Conclusion: This study demonstrates the clinical effectiveness of SET programs following current guidelines and potential utilization of non-TM walking modalities in SET programs., Competing Interests: All authors declare no conflicts of interest., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
23. Relation of non-exercise walking activity with exercise performance in patients with peripheral artery disease: NEW activity for PAD.
- Author
-
Mays RJ, Kahnke R, Schorr EN, and Treat-Jacobson D
- Subjects
- Humans, Exercise, Intermittent Claudication, Walking, Exercise Test, Treatment Outcome, Exercise Therapy, Peripheral Arterial Disease
- Abstract
Introduction: Community-based structured exercise training (CB-SET) programs are beneficial for patients with peripheral artery disease (PAD). However, the impact of lower levels of walking activity accumulated separately from formal exercise is unclear. The aim of this study was to determine the relation of non-exercise walking (NEW) activity with exercise performance in PAD., Methods: This was a post hoc analysis from twenty patients with PAD enrolled in a 12 week CB-SET program using diaries and accelerometry. Formal exercise (3 sessions·week
-1 ) was detected using patient-reported diary entries that corresponded with accelerometer step data. NEW activity was characterized as steps completed over five days each week, excluding steps achieved during formal exercise sessions. The primary exercise performance outcome was peak walking time (PWT) assessed on a graded treadmill. Secondary performance outcomes included claudication onset time (COT) from the graded treadmill and peak walking distance (PWD) achieved during the six-minute walk test (6MWT). Partial Pearson correlations evaluated the relation of NEW activity (step·week-1 ) with exercise performance outcomes using exercise session intensity (step·week-1 ) and duration (min·week-1 ) as covariates., Results: NEW activity demonstrated a moderate, positive correlation with change in PWT (r=0.50, p=0.04). Other exercise performance outcomes were not significantly related to NEW activity (COT: r=0.14; 6MWT PWD: r=0.27)., Conclusions: A positive association was demonstrated between NEW activity and PWT following 12 weeks of CB-SET. Interventions to increase physical activity levels outside of formal exercise sessions may be beneficial for patients with PAD., Competing Interests: Declaration of Competing Interest The authors have no potential conflicts of interest with respect to the research, authorship, and publication of this article., (Copyright © 2022. Published by Elsevier Inc.)- Published
- 2023
- Full Text
- View/download PDF
24. Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies.
- Author
-
Powell CA, Kim GY, Edwards SN, Aalami O, Treat-Jacobson D, Byrnes ME, Osborne NH, and Corriere MA
- Subjects
- Humans, Female, Middle Aged, Aged, Aged, 80 and over, Child, Preschool, Male, Quality of Life, Intermittent Claudication therapy, Intermittent Claudication drug therapy, Walking, Patient-Centered Care, Goals, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease therapy
- Abstract
Objective: Patient-reported outcomes (PRO) have been increasingly emphasized for peripheral artery disease (PAD). Patient-defined treatment goals and expectations, however, are poorly understood and might not be achievable or aligned with guidelines or clinical outcomes. We evaluated the patient-reported treatment goals among patients with claudication and the associations between patient characteristics, goals, and PAD-specific PRO scores., Methods: Patients with a diagnosis of claudication were prospectively recruited. Patient-defined treatment goals and outcomes related to walking distance, duration, and speed were quantified using multiple-choice survey items. Free-text items were used to identify activities other than walking distance, duration, or speed associated with symptoms and treatment goals. The peripheral artery disease quality of life and walking impairment questionnaire instruments were included as PRO. The treatment goal categories were compared with the PRO percentile scores using 95% confidence intervals (CIs), categorical tests, and logistic regression models. Associations between the patient characteristics and PRO were evaluated using linear and ordinal logistic regression models., Results: A total of 150 patients meeting the inclusion criteria were included in the present study. Of these 150 patients, 144 (96%) viewed the entire survey. Their mean age was 70.0 ± 11.3 years, and 32.9% were women. Most of the respondents had self-reported their race as White (n = 135), followed by Black (n = 3), Asian (n = 2), Native American (n = 2), and other/unknown (n = 2). Two participants self-reported Hispanic ethnicity. The primary treatment goals were an increased walking distance or duration without stopping (62.0%), the ability to perform a specific activity or task (23.0%), an increased walking speed (8.0%), or other/none of the above (7.0%). The specific activities associated with symptoms or goals included outdoor recreation (38.5%), labor-related tasks (30.7%), sports (26.9%), climbing stairs (23.1%), uphill walking (19.2%), and shopping (6%). Among the patients choosing an increased walking distance and duration as the primary goals, 64% had indicated that a distance of ≥0.5 mile (2640 ft) and 59% had indicated a duration of ≥30 minutes would be a minimum increase consistent with meaningful improvement. Increasing age was associated with lower odds of a distance improvement goal of ≥0.5 mile (odds ratio [OR], 0.68 per 5 years; 95% CI, 0.51-0.92; P = .012) or duration improvement goal of ≥30 minutes (OR, 0.76 per 5 years; 95% CI, 0.58-0.99; P = .047). Patient characteristics associated with PAD Quality of Life percentile scores included age, ankle brachial index, and gender. Ankle brachial index was the only patient characteristic associated with the walking impairment questionnaire percentile scores., Conclusions: Patients define treatment goals according to their desired activities and expectations, which may influence their goals and perceived outcomes. Patients' expectations of minimum increases in walking distance and duration consistent with meaningful improvement exceeded reported minimum important difference criteria for many patients and would not be captured using common clinic-based walking tests. Patient age was associated with both treatment goals and PRO scores, and the related floor and ceiling effects could influence sensitivity to PRO changes for younger and older patients, respectively. Heterogeneity in treatment goals supports consideration of tailored decision-making and outcomes informed by patient characteristics and perspectives., (Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
25. Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease.
- Author
-
Cetlin MD, Polonsky T, Ho K, Zhang D, Tian L, Zhao L, Greenland P, Treat-Jacobson D, Kibbe MR, Criqui MH, Guralnik JM, and McDermott MM
- Subjects
- Humans, Aged, Female, United States, Middle Aged, Male, Medicare, Exercise Therapy, Walking, Intermittent Claudication diagnosis, Intermittent Claudication therapy, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease therapy
- Abstract
Objective: This study identified barriers to participation in supervised exercise therapy covered by the Centers for Medicare and Medicaid Services (CMS), reported by people with lower extremity peripheral artery disease (PAD)., Methods: People with PAD participating in research studies of walking impairment due to PAD in the Chicagoland area were asked to complete a questionnaire between March 15, 2019, and July 12, 2022, assessing their experience and attitudes about supervised exercise therapy. Participants were identified using mailed postcards to people aged 50 and older in Chicagoland, from medical centers in Chicago, and using bus and train advertisements. The questionnaire was developed based on focus group feedback from people with PAD., Results: Of 516 participants with PAD approached, 489 (94.8%) completed the questionnaire (mean age: 71.0 years [standard deviation: 8.7], mean ankle-brachial index: 0.71 [standard deviation: 0.25]; 204 [41.7%] women and 261 [53.4%] Black). Of the 489 participants, 416 (85.1%) reported that their physician had never prescribed or recommended supervised exercise therapy. Overall, 357 (73.2%) reported willingness to travel three times weekly to the medical center for supervised exercise participation. However, of these, 214 (59.9%) reported that they were unwilling or unable to pay the $11 per exercise session copay required for supervised exercise covered by CMS. Of 51 people with PAD who reported prior participation in supervised exercise, only 5 (9.8%) completed the 12 weeks of supervised exercise therapy covered by CMS and 29 (56.9%) completed 6 or fewer weeks. Of 131 (26.8%) unwilling to travel three times weekly to a center for supervised exercise, the most common reasons for unwillingness to participate were "too time-consuming" (55.0%), "too inconvenient" (45.8%), and "lack of interest in treadmill exercise" (28.2%)., Conclusions: Approximately 2 to 4 years after CMS began covering supervised exercise for PAD, most people with PAD in this study from a large urban area had not participated in supervised exercise therapy. Of those who participated, most completed fewer than half of the sessions covered by CMS. The required CMS copayment was a common barrier to supervised exercise participation by people with PAD., (Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
26. Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease: A REVIEW OF CURRENT EXPERIENCE AND PRACTICE-BASED RECOMMENDATIONS.
- Author
-
Ehrman JK, Gardner AW, Salisbury D, Lui K, and Treat-Jacobson D
- Subjects
- Aged, Humans, United States, Intermittent Claudication therapy, Exercise Therapy methods, Walking, Medicare, Peripheral Arterial Disease therapy
- Abstract
Purpose: This review encompasses several practical components of supervised exercise therapy (SET) for patients with claudication including referral, exercise training, and billing issues. Real-life SET session examples are also provided. SET was approved for reimbursement by the Centers for Medicare & Medicaid Services (CMS) in 2017, and there is continual growth of programs offering SET and in participation. The purpose of this review is to provide useful information for the clinical exercise professionals working with these patients., Review Methods: The 2016 ACC/AHA Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (PAD) provided a class I (highest level) recommendation for the use of SET in those with symptomatic PAD. Since there has been much growth in the literature about the utility of SET, the literature was reviewed (PubMed) to provide information for this article. Topics reviewed include the benefits of exercise training, exercise prescription, billing, referral and participation, and best practices., Summary: SET should be offered to all patients with symptomatic PAD who are not at risk of acute limb ischemia. For optimal results, SET should be implemented several times per week and in a progressive process to increase exercise intensity as tolerated. For best results, programs should recommend patients supplement SET with home exercise. Considerations for utilizing reimbursed sessions should also be discussed because patients have a maximum of 72 sessions/lifetime. Referral practices need refinement, and participation rates remain extremely low and may be influenced by demographics. Research on best practices and home or hybrid training must continue to address issues related to common enrollment and participation barriers., Condensed Abstract: Supervised exercise training (SET) for symptomatic peripheral artery disease is a class IA recommendation and reimbursable by most insurances. Improvements in walking performance can be dramatic. However, referral and participation in SET remain very low and thus SET is vastly underutilized., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
27. Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial.
- Author
-
Hammond MM, Spring B, Rejeski WJ, Sufit R, Criqui MH, Tian L, Zhao L, Xu S, Kibbe MR, Leeuwenburgh C, Manini T, Forman DE, Treat-Jacobson D, Polonsky TS, Bazzano L, Ferrucci L, Guralnik J, Lloyd-Jones DM, and McDermott MM
- Subjects
- Exercise Therapy methods, Female, Humans, Lower Extremity, Male, Physical Functional Performance, Walking, Leg, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease therapy
- Abstract
Background In people with peripheral artery disease, post hoc analyses of the LITE (Low Intensity Exercise Intervention in Peripheral Artery Disease) randomized trial were conducted to evaluate the effects of walking exercise at a pace inducing ischemic leg symptoms on walking velocity and the Short Physical Performance Battery, compared with walking exercise without ischemic leg symptoms and compared with a nonexercising control group. Methods and Results Participants with peripheral artery disease were randomized to: home-based walking exercise that induced ischemic leg symptoms; home-based walking exercise conducted without ischemic leg symptoms; or a nonexercising control group for 12 months. Outcomes were change of walking velocity over 4 m and change of the Short Physical Performance Battery (0-12, with 12=best) at 6- and 12-month follow-up. A total of 264 participants (48% women, 61% Black race) were included. Compared with walking exercise without ischemic symptoms, walking exercise that induced ischemic symptoms improved change in usual-paced walking velocity over 4 m at 6-month (0.056 m/s [95% CI, 0.019-0.094 m/s]; P <0.01) and 12-month follow-up (0.084 m/s [95% CI, 0.049-0.120 m/s]; P <0.01), change in fast-paced of walking velocity over 4 m at 6-month follow-up ( P =0.03), and change in the Short Physical Performance Battery at 12-month follow-up (0.821 [95% CI, 0.309-1.334]; P <0.01). Compared with control, walking exercise at a pace inducing ischemic symptoms improved change in usual-paced walking velocity over 4 m at 6-month follow-up (0.066 m/s [95% CI, 0.021-0.111 m/s]; P <0.01). Conclusions In people with peripheral artery disease, those who walked for exercise at a comfortable pace without ischemic leg symptoms slowed their walking speed during daily life and worsened the Short Physical Performance Battery score, a potentially harmful effect, compared with people who walked for exercise at a pace inducing ischemic leg symptoms. Compared with a control group who did not exercise, home-based walking exercise at a pace inducing ischemic leg symptoms significantly improved change of walking velocity over 4 m at 6-month follow-up, but this benefit did not persist at 12-month follow-up. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02538900.
- Published
- 2022
- Full Text
- View/download PDF
28. Decision Aids for Determining Facility Versus Non-Facility-Based Exercise in Those with Symptomatic Peripheral Artery Disease.
- Author
-
Ehrman JK, Salisbury D, and Treat-Jacobson D
- Subjects
- Decision Support Techniques, Exercise, Exercise Therapy, Humans, Intermittent Claudication, Pain, Walking, Peripheral Arterial Disease therapy
- Abstract
Purpose of Review: This paper sought to provide rationale for determining when a patient with symptomatic peripheral artery disease (PAD) might be referred for home-based versus facility-based exercise therapy., Recent Findings: Multiple randomized controlled studies have embedded supervised, structured exercise therapy as a class IA recommended therapy for those with symptomatic PAD. More recently, there is interest in non-facility-based exercise training as an alternative. The current literature is mixed on the effectiveness of non-facility-based training and is influenced by the amount of contact with clinical staff providing some supervision (e.g., occasional facility-based exercise or coaching phone calls), and the intensity (e.g., performed intermittently by inducing pain or continually and not inducing pain) and frequency (e.g., 12-week common supervised exercise program or those longer than 24 weeks) of exercise. Certainly, the data suggests non-facility-based exercise, while possibly improving walking performance, is inferior to facility-based supervised exercise training. Comprehensive data is lacking on utilization of supervised exercise therapy in those with symptomatic PAD, but is likely <2% of those eligible who participate. This suggests a possible important role for alternatives including non-facility-based (e.g., home, fitness center). Exercise training in the supervised, facility-based setting appears to be greatly underutilized. Non-facility-based exercise may help to overcome some of the most common barriers to participating in facility-based exercise including those related to motivation, transportation, and proximity. However, facility-based training is considered the gold standard so decisions about allowing a patient to exercise train at home must take into account issues including disease severity, patient motivation and available exercise resources, mobility and balance, cognitive function, and other medical concerns (e.g., symptomatic coronary artery disease or heart failure)., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
29. What does the future hold for structured exercise training for people with PAD? Ideas from two Masters of the Society for Vascular Medicine.
- Author
-
Regensteiner JG and Treat-Jacobson D
- Subjects
- Exercise, Exercise Therapy, Humans, Intermittent Claudication, Cardiology, Peripheral Arterial Disease
- Published
- 2022
- Full Text
- View/download PDF
30. Total body recumbent stepping vs treadmill walking in supervised exercise therapy: A pilot study.
- Author
-
Salisbury DL, Swanson K, Brown RJ, and Treat-Jacobson D
- Subjects
- Exercise Therapy adverse effects, Humans, Intermittent Claudication therapy, Pilot Projects, Single-Blind Method, Treatment Outcome, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease therapy, Walking
- Abstract
Background: Treadmill walking is the most commonly recommended exercise modality in supervised exercise therapy (SET) for peripheral artery disease (PAD); however, other modalities may be equally effective and more tolerable for patients. The primary aim of this single-blind, randomized pilot study was to compare the feasibility, safety, and preliminary efficacy of a treadmill walking (TM) versus a total body recumbent stepping (TBRS) exercise program for treatment of PAD (i.e., "Stepper Study").. Methods: Participants ( n = 19) enrolled in a 12-week SET program and were randomized to either a TM ( n = 9) or TBRS ( n = 10) exercise group that followed current SET exercise guidelines. Feasibility, safety, and efficacy outcomes were assessed. Results: SET attendance was 86% and 71%, respectively, for TBRS and TM groups ( p = 0.07). Session exercise dose (metabolic equivalents of task [MET] minutes) (mean [SD]) for TM was 117.6 [27.4] compared to 144.7 [28.7] in the TBRS group ( p = 0.08). Study-related adverse events were nine in 236 training hours and three in 180 training hours for the TBRS and TM groups, respectively. There were no significant differences between groups for improvement in 6-minute walk distance (mean [SD]) (TM: 133.2 ft [53.5] vs TBRS: 154.8 ft [49.8]; p = 0.77) after adjusting for baseline 6-minute walk distance. Conclusion: This is the first randomized study comparing TBRS to TM exercise in SET using current SET guidelines. This pilot study showed that TBRS is a feasible and safe exercise modality in SET. This study provides preliminary efficacy of the use of TBRS exercise in SET programs following current guidelines. Larger studies should be conducted to confirm these findings.
- Published
- 2022
- Full Text
- View/download PDF
31. Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial.
- Author
-
Slysz JT, Rejeski WJ, Treat-Jacobson D, Bazzano LA, Forman DE, Manini TM, Criqui MH, Tian L, Zhao L, Zhang D, Guralnik JM, Ferrucci L, Kibbe MR, Polonsky TS, Spring B, Sufit R, Leeuwenburgh C, and McDermott MM
- Subjects
- Ankle Brachial Index, Cross-Sectional Studies, Exercise, Humans, Physical Functional Performance, Severity of Illness Index, Walking, Peripheral Arterial Disease diagnosis, Quality of Life
- Abstract
This study investigated cross-sectional associations of peripheral artery disease (PAD) severity (defined by the ankle-brachial index (ABI)) and amounts of daily sustained physical activity (PA) (defined as > 100 activity counts per minute lasting 5 consecutive minutes or more). This study also investigated associations of amounts of daily sustained PA with 6-minute walk (6MW) distance and the Short Form-36 physical functioning domain (SF-36 PF) score in cross-sectional analyses and with serious adverse events (SAEs) in longitudinal analyses of people with PAD. PA was measured continuously for 10 days using a tri-axial accelerometer at baseline in 277 participants with PAD randomized to the LITE clinical trial. In regression analyses, each 0.15 lower ABI value was associated with a 5.67% decrease in the number of daily bouts of sustained PA (95% CI: 3.85-6.54; p < 0.001). Every additional bout of sustained PA per day was associated with a 4.56-meter greater 6MW distance (95% CI: 2.67-6.46; p < 0.0001), and a 0.81-point improvement in SF-36 PF score (95% CI: 0.34-1.28; p < 0.001). Participants with values of daily bouts of sustained PA below the median had higher rates of SAEs during follow-up, compared to participants above the median (41% vs 24%; p = 0.002). In conclusion, among participants with PAD, lower ABI values were associated with fewer bouts of daily sustained PA. A greater number of bouts of daily sustained PA were associated with better 6MW performance and SF-36 PF score, and, in longitudinal analyses, lower rates of SAEs. Clinicaltrials.gov ID: NCT02538900.
- Published
- 2021
- Full Text
- View/download PDF
32. Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas.
- Author
-
Fanaroff AC, Yang L, Nathan AS, Khatana SAM, Julien H, Wang TY, Armstrong EJ, Treat-Jacobson D, Glaser JD, Wang G, Damrauer SM, Giri J, and Groeneveld PW
- Subjects
- Aged, Humans, Lower Extremity surgery, United States epidemiology, Amputation, Surgical statistics & numerical data, Healthcare Disparities, Medicare, Peripheral Arterial Disease epidemiology, Peripheral Arterial Disease surgery, Social Class
- Abstract
Background Rates of major lower extremity amputation in patients with peripheral artery disease are higher in rural communities with markers of low socioeconomic status, but most Americans live in metropolitan areas. Whether amputation rates vary within US metropolitan areas is unclear, as are characteristics of high amputation rate urban communities. Methods and Results We estimated rates of major lower extremity amputation per 100 000 Medicare beneficiaries between 2010 and 2018 at the ZIP code level among ZIP codes with ≥100 beneficiaries. We described demographic characteristics of high and low amputation ZIP codes, and the association between major amputation rate and 3 ZIP code-level markers of socioeconomic status-the proportion of patients with dual eligibility for Medicaid, median household income, and Distressed Communities Index score-for metropolitan, micropolitan, and rural ZIP code cohorts. Between 2010 and 2018, 188 995 Medicare fee-for-service patients living in 31 391 ZIP codes with ≥100 beneficiaries had a major lower extremity amputation. The median (interquartile range) ZIP code-level number of amputations per 100 000 beneficiaries was 262 (75-469). Though nonmetropolitan ZIP codes had higher rates of major amputation than metropolitan areas, 78.2% of patients undergoing major amputation lived in metropolitan areas. Compared with ZIP codes with lower amputation rates, top quartile amputation rate ZIP codes had a greater proportion of Black residents (4.4% versus 17.5%, P <0.001). In metropolitan areas, after adjusting for clinical comorbidities and demographics, every $10 000 lower median household income was associated with a 4.4% (95% CI, 3.9-4.8) higher amputation rate, and a 10-point higher Distressed Communities Index score was associated with a 3.8% (95% CI, 3.4%-4.2%) higher amputation rate; there was no association between the proportion of patients eligible for Medicaid and amputation rate. These findings were comparable to the associations identified across all ZIP codes. Conclusions In metropolitan areas, where most individuals undergoing lower extremity amputation live, markers of lower socioeconomic status and Black race were associated with higher rates of major lower extremity amputation. Development of community-based tools for peripheral artery disease diagnosis and management targeted to communities with high amputation rates in urban areas may help reduce inequities in peripheral artery disease outcomes.
- Published
- 2021
- Full Text
- View/download PDF
33. Individual Differences in Response to Supervised Exercise Therapy for Peripheral Artery Disease.
- Author
-
Whipple MO, Schorr EN, Talley KMC, Wolfson J, Lindquist R, Bronas UG, and Treat-Jacobson D
- Subjects
- Aged, Exercise Therapy, Female, Humans, Individuality, Intermittent Claudication therapy, Male, Walking physiology, Peripheral Arterial Disease therapy, Quality of Life
- Abstract
Nonresponse to exercise has been extensively examined in young athletes but is seldom reported in studies of aerobic exercise interventions in older adults. This study examined the prevalence of nonresponse and poor response to exercise in functional and quality of life outcomes and response patterns between and among older adults undergoing 12-weeks of supervised exercise therapy for the management of peripheral artery disease ( N = 44, mean age 72.3 years, 47.7% female). The prevalence of nonresponse (no change/decline in performance) in walking distance was 31.8%. The prevalence of poor response (lack of a clinically meaningful improvement) was 43.2%. Similar patterns of response were observed in both objective and patient-reported measures of physical function. All participants improved in at least one outcome; only two participants improved in all measured outcomes. Additional research should examine modifiable predictors of response to inform programming and maximize an individual's potential benefit from exercise therapy.
- Published
- 2021
- Full Text
- View/download PDF
34. Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial.
- Author
-
McDermott MM, Spring B, Tian L, Treat-Jacobson D, Ferrucci L, Lloyd-Jones D, Zhao L, Polonsky T, Kibbe MR, Bazzano L, Guralnik JM, Forman DE, Rego A, Zhang D, Domanchuk K, Leeuwenburgh C, Sufit R, Smith B, Manini T, Criqui MH, and Rejeski WJ
- Subjects
- Aged, Biopsy, Female, Humans, Ischemia therapy, Lower Extremity blood supply, Lower Extremity pathology, Male, Muscle, Skeletal pathology, Peripheral Arterial Disease pathology, Peripheral Arterial Disease physiopathology, Walk Test, Exercise Therapy methods, Peripheral Arterial Disease therapy, Walking
- Abstract
Importance: Supervised high-intensity walking exercise that induces ischemic leg symptoms is the first-line therapy for people with lower-extremity peripheral artery disease (PAD), but adherence is poor., Objective: To determine whether low-intensity home-based walking exercise at a comfortable pace significantly improves walking ability in people with PAD vs high-intensity home-based walking exercise that induces ischemic leg symptoms and vs a nonexercise control., Design, Setting, and Participants: Multicenter randomized clinical trial conducted at 4 US centers and including 305 participants. Enrollment occurred between September 25, 2015, and December 11, 2019; final follow-up was October 7, 2020., Interventions: Participants with PAD were randomized to low-intensity walking exercise (n = 116), high-intensity walking exercise (n = 124), or nonexercise control (n = 65) for 12 months. Both exercise groups were asked to walk for exercise in an unsupervised setting 5 times per week for up to 50 minutes per session wearing an accelerometer to document exercise intensity and time. The low-intensity group walked at a pace without ischemic leg symptoms. The high-intensity group walked at a pace eliciting moderate to severe ischemic leg symptoms. Accelerometer data were viewable to a coach who telephoned participants weekly for 12 months and helped them adhere to their prescribed exercise. The nonexercise control group received weekly educational telephone calls for 12 months., Main Outcomes and Measures: The primary outcome was mean change in 6-minute walk distance at 12 months (minimum clinically important difference, 8-20 m)., Results: Among 305 randomized patients (mean age, 69.3 [SD, 9.5] years, 146 [47.9%] women, 181 [59.3%] Black patients), 250 (82%) completed 12-month follow-up. The 6-minute walk distance changed from 332.1 m at baseline to 327.5 m at 12-month follow-up in the low-intensity exercise group (within-group mean change, -6.4 m [95% CI, -21.5 to 8.8 m]; P = .34) and from 338.1 m to 371.2 m in the high-intensity exercise group (within-group mean change, 34.5 m [95% CI, 20.1 to 48.9 m]; P < .001) and the mean change for the between-group comparison was -40.9 m (97.5% CI, -61.7 to -20.0 m; P < .001). The 6-minute walk distance changed from 328.1 m at baseline to 317.5 m at 12-month follow-up in the nonexercise control group (within-group mean change, -15.1 m [95% CI, -35.8 to 5.7 m]; P = .10), which was not significantly different from the change in the low-intensity exercise group (between-group mean change, 8.7 m [97.5% CI, -17.0 to 34.4 m]; P = .44). Of 184 serious adverse events, the event rate per participant was 0.64 in the low-intensity group, 0.65 in the high-intensity group, and 0.46 in the nonexercise control group. One serious adverse event in each exercise group was related to study participation., Conclusions and Relevance: Among patients with PAD, low-intensity home-based exercise was significantly less effective than high-intensity home-based exercise and was not significantly different from the nonexercise control for improving 6-minute walk distance. These results do not support the use of low-intensity home-based walking exercise for improving objectively measured walking performance in patients with PAD., Trial Registration: ClinicalTrials.gov Identifier: NCT02538900.
- Published
- 2021
- Full Text
- View/download PDF
35. Influence of Changes in Sedentary Time on Outcomes of Supervised Exercise Therapy in Individuals with Comorbid Peripheral Artery Disease and Type 2 Diabetes.
- Author
-
Whipple MO, Schorr EN, Talley KMC, Wolfson J, Lindquist R, Bronas UG, and Treat-Jacobson D
- Subjects
- Aged, Comorbidity, Diabetes Mellitus, Type 2 diagnosis, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 physiopathology, Exercise Tolerance, Female, Humans, Intermittent Claudication diagnosis, Intermittent Claudication epidemiology, Intermittent Claudication physiopathology, Male, Minnesota epidemiology, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease epidemiology, Peripheral Arterial Disease physiopathology, Pilot Projects, Recovery of Function, Time Factors, Treatment Outcome, Diabetes Mellitus, Type 2 therapy, Exercise Therapy, Intermittent Claudication therapy, Peripheral Arterial Disease therapy, Sedentary Behavior, Walking
- Abstract
Background: Although supervised exercise therapy (SET) is effective in improving walking distance among adults with symptomatic peripheral artery disease (PAD), some research suggests that individuals with comorbid PAD and type 2 diabetes mellitus (T2DM) may experience a blunted response to SET. It is unknown whether free-living sedentary time changes during SET, and if increases in sedentary time could, in part, explain poor response to SET. The purposes of this pilot study were to (1) determine if older adults with PAD (with and without T2DM) engaging in SET change their sedentary behavior and (2) examine the relationship between changes in sedentary behavior and SET outcomes. We hypothesized that decreased sedentary time during SET would be associated with greater improvements in six-minute walk test (6MWT) total distance and other key SET outcomes., Methods: Participants (n = 44) initiating a 12-week SET program completed the 6MWT, Short Physical Performance Battery, Walking Impairment Questionnaire, and accelerometer-assessed sedentary behavior at SET initiation, 6 weeks, and 12 weeks., Results: Participants' mean age was 72.3 (7.1) years, mean ankle-brachial index was 0.71 (0.25), and 47.7% were female. On average, sedentary time did not change after SET, although there was substantial variability (-40% to +38% change in minutes of sedentary time/day). Participants with T2DM experienced greater improvements in claudication onset distance than participants without T2DM (mean = 35 m, P = 0.044, 95% confidence interval = 1.6 to 115.4 m). Neither changes in sedentary time from baseline to 6 weeks (P = 0.419) nor T2DM (P = 0.154) predicted changes in 6MWT total distance from baseline to 12 weeks., Conclusions: As SET availability increases, further examination of factors that may influence SET outcomes will help maximize benefits of this proven therapy., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
36. Adherence and exercise mode in supervised exercise therapy for peripheral artery disease.
- Author
-
Elgersma KM, Brown RJL, Salisbury DL, Stigen L, Gildea L, Larson K, Schorr EN, Kirk LN, and Treat-Jacobson D
- Subjects
- Aged, Ankle Brachial Index, Exercise Tolerance, Female, Humans, Male, Directly Observed Therapy, Exercise Therapy, Peripheral Arterial Disease therapy, Walking
- Abstract
Supervised exercise therapy (SET) is a first-line treatment for people with peripheral artery disease (PAD). However, data on patient adherence to SET are limited. In addition, while intermittent treadmill exercise has been widely tested, no studies have investigated recumbent total body stepping (step-ex). We examined whether exercise mode (treadmill walking [n = 17], step-ex [n = 18], or a multimodal approach [n = 18]) affected adherence to a 12-week SET program. We also investigated the potential safety and viability of step-ex for people with PAD by looking at change in exercise training capacity (highest metabolic equivalent of tasks [METs] achieved and highest total MET-minutes achieved per session). The 53 participants comprised 50% female candidates (n = 26) and were (mean [SD]) 74.2 (8.3) years old, with an ankle-brachial index of 0.70 (0.19). Overall adherence to SET was 62%. There was a difference in adherence between groups (P = .022), with the multimodal group (73.6% [21.5%]) higher than the treadmill group (50.2% [28.8%], P = .010). Treadmill participants (n [%]) (8 [47.1%]) dropped out at a higher rate than the multimodal group (3 [16.7%], P = .053). All groups increased the exercise training capacity. The multimodal group achieved greater improvement in total MET-minutes achieved per session (61.5 [45.1]) than the treadmill group (14.7 [44.3]) (P = .008).A multimodal approach to PAD exercise therapy resulted in higher adherence and greater change in exercise training capacity. Step-ex was safe for people with PAD. While further study is warranted, it is appropriate for SET programs to consider a multimodal approach using step-ex, especially given the varied health and physical ability of the PAD population., (Copyright © 2020 Society for Vascular Nursing. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
37. Society for Vascular Nursing endovascular repair of abdominal aortic aneurysm updated nursing clinical practice guideline.
- Author
-
Kohlman-Trigoboff D, Rich K, Foley A, Fitzgerald K, Arizmendi D, Robinson C, Brown R, and Treat-Jacobson D
- Subjects
- Aged, Evidence-Based Practice, Female, Humans, Male, Risk Factors, Aortic Aneurysm, Abdominal surgery, Cardiovascular Nursing, Endovascular Procedures, Practice Guidelines as Topic
- Published
- 2020
- Full Text
- View/download PDF
38. Membership spotlight.
- Author
-
Campia U, Snyder J, Rizzo S, and Treat-Jacobson D
- Subjects
- Career Choice, History, 20th Century, History, 21st Century, Humans, Mentors history, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease therapy, Biomedical Research history, Cardiology history, Committee Membership, Peripheral Arterial Disease history, Societies, Medical
- Published
- 2020
- Full Text
- View/download PDF
39. Vascular Disease Patient Information Page: Exercise for peripheral artery disease.
- Author
-
Treat-Jacobson D and Ratchford EV
- Subjects
- Humans, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease physiopathology, Treatment Outcome, Exercise Therapy, Peripheral Arterial Disease therapy
- Published
- 2020
- Full Text
- View/download PDF
40. Review of article: Goldman M.P., Clark C.J., Craven T.E., Davis R.P., Williams T.K., Velazquez-Ramirez G., Hurie J.B., Edwards M.S. Effect of intensive glycemic control on risk of lower extremity amputation. J Am Coll Surg 2018;227:596-604.
- Author
-
Treat-Jacobson D
- Subjects
- Humans, Lower Extremity, Amputation, Surgical, Blood Glucose
- Published
- 2019
- Full Text
- View/download PDF
41. Considerations for accurate blood pressure measurement in clinical care and research.
- Author
-
Brown RJL, Rich K, and Treat-Jacobson D
- Subjects
- Adult, Aged, 80 and over, Female, Humans, Weight Loss physiology, Blood Pressure physiology, Blood Pressure Determination, Guidelines as Topic
- Published
- 2019
- Full Text
- View/download PDF
42. Implementation of Supervised Exercise Therapy for Patients With Symptomatic Peripheral Artery Disease: A Science Advisory From the American Heart Association.
- Author
-
Treat-Jacobson D, McDermott MM, Beckman JA, Burt MA, Creager MA, Ehrman JK, Gardner AW, Mays RJ, Regensteiner JG, Salisbury DL, Schorr EN, and Walsh ME
- Subjects
- Advisory Committees, American Heart Association, Centers for Medicare and Medicaid Services, U.S., Home Care Services, Humans, Organization and Administration, Patient Outcome Assessment, Peripheral Arterial Disease rehabilitation, Practice Guidelines as Topic, Quality of Life, United States, Exercise Therapy methods, Peripheral Arterial Disease therapy
- Abstract
Patients with lower-extremity peripheral artery disease (PAD) have greater functional impairment, faster functional decline, increased rates of mobility loss, and poorer quality of life than people without PAD. Supervised exercise therapy (SET) improves walking ability, overall functional status, and health-related quality of life in patients with symptomatic PAD. In 2017, the Centers for Medicare & Medicaid Services released a National Coverage Determination (CAG-00449N) for SET programs for patients with symptomatic PAD. This advisory provides a practical guide for delivering SET programs to patients with PAD according to Centers for Medicare & Medicaid Services criteria. It summarizes the Centers for Medicare & Medicaid Services process and requirements for referral and coverage of SET and provides guidance on how to implement SET for patients with PAD, including the SET protocol, options for outcome measurement, and transition to home-based exercise. This advisory is based on the guidelines established by the Centers for Medicare & Medicaid Services for Medicare beneficiaries in the United States and is intended to assist clinicians and administrators who are implementing SET programs for patients with PAD.
- Published
- 2019
- Full Text
- View/download PDF
43. A case study of recumbent cross-training in supervised exercise therapy for peripheral artery disease (PAD).
- Author
-
Brown RJL, Salisbury DL, and Treat-Jacobson D
- Subjects
- Accelerometry, Aged, Female, Humans, Intermittent Claudication, Male, Exercise Therapy statistics & numerical data, Peripheral Arterial Disease therapy, Walking statistics & numerical data
- Published
- 2019
- Full Text
- View/download PDF
44. A mixed methods study of perceived barriers to physical activity, geriatric syndromes, and physical activity levels among older adults with peripheral artery disease and diabetes.
- Author
-
Whipple MO, Schorr EN, Talley KMC, Lindquist R, Bronas UG, and Treat-Jacobson D
- Subjects
- Accidental Falls prevention & control, Aged, Female, Humans, Male, Pain, Self Report, Social Support, Surveys and Questionnaires, Diabetes Mellitus, Type 2 complications, Exercise physiology, Exercise psychology, Health Status, Motivation, Peripheral Arterial Disease complications, Quality of Life psychology
- Abstract
Previous studies suggest a myriad of factors prevent individuals from engaging in physical activity; however, less is known about barriers faced by individuals with multiple chronic conditions, such as peripheral artery disease (PAD) and type 2 diabetes, and how these barriers may impact engagement in physical activity. To date, there are no studies that integrate simultaneous assessment of perceived barriers to physical activity and engagement in physical activity in older adults with PAD and diabetes. This integration is key to understanding the implications of barriers to physical activity and to developing strategies to address those barriers. Therefore, this study investigated the unique physical activity experiences of older adults with PAD and diabetes. This study used a concurrent mixed methods design. Ten adults aged 65 years and older with PAD and diabetes completed semistructured interviews about experiences with physical activity, self-reported questionnaires assessing quality of life and fear of falling, and measures of physical function (eg, 6-minute walk test, chair stand, gait speed). Physical activity was measured objectively with accelerometry. Inductive content analysis was used to identify themes, and integrated analysis was performed to evaluate patterns among qualitative and quantitative variables. On average, participants were 74 years old and spent 10% of their time in moderate or vigorous physical activity (range: 3%-18%); 80% of participants were men. Barriers to physical activity identified through qualitative interviews included lack of accessibility, lack of enjoyment of activity, lack of motivation, and pain and physical health. Facilitators to physical activity were social support, accessibility and convenience, and enjoyment of the activity. Participants with more sedentary time and less moderate or vigorous physical activity tended to report greater fear of falling and greater barriers to physical activity and achieved lower distances in 6-minute walk tests. This research provides insight into both the nature of perceived barriers to physical activity and engagement in physical activity among older adults with PAD and diabetes. The integration of self-reported measures and objective measures facilitates our understanding of the lived experiences of individuals with these conditions. Study findings can be used to support further investigation into factors that influence engagement in physical activity in individuals with PAD and diabetes and to assist in the development of strategies to address identified barriers., (Copyright © 2019 Society for Vascular Nursing. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
45. Experience Implementing Supervised Exercise Therapy for Peripheral Artery Disease.
- Author
-
Salisbury DL, Whipple MO, Burt M, Brown R, Mays RJ, Bakken M, and Treat-Jacobson D
- Abstract
Background: Supervised exercise therapy (SET) is a cornerstone of treatment for improving walking distance for individuals with symptomatic peripheral artery disease and claudication. High quality randomized controlled trials have documented the efficacy of SET as a claudication treatment and led to the recent Centers for Medicare and Medicaid decision to cover supervised exercise therapy (SET). However, to date, the translation of highly controlled, laboratory based SET programs in real world cardiopulmonary rehabilitation settings has been unexplored., Methods: In this article, we describe our experience integrating SET into existing cardiopulmonary rehabilitation programs, focusing on patient evaluation, exercise prescription, outcome assessments, strategies to maximize program adherence, and transitioning to home and community-based exercise training., Results: Our team has over 3 years experience successfully implementing SET in cardiac rehabilitation settings. The experiences communicated within can serve as a model for rehabilitation therapists to follow as they begin to incorporate SET in their rehabilitation programs., Conclusions: CMS reimbursement has the potential to change clinical practice and utilization of SET for patients with symptomatic peripheral artery disease. The experience we have gained through implementation of SET programs across the M Health and Fairview Health Systems and in other Minnesota communities, including specific elements in our programs and the lessons learned from our clinical experience, can inform and help to guide development of new programs., Brief Abstract: The recent Centers for Medicare and Medicaid decision to cover supervised exercise therapy (SET) for beneficiaries with peripheral artery disease (PAD) has the potential to transform practice. In this article, we describe our experience integrating SET into existing cardiopulmonary rehabilitation programs, which could serve as a model for new programs., Competing Interests: No conflicts of interest.
- Published
- 2019
- Full Text
- View/download PDF
46. Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association.
- Author
-
Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH, Gardner AW, Hiatt WR, Regensteiner JG, and Rich K
- Subjects
- Consensus, Exercise Test, Exercise Therapy adverse effects, Humans, Intermittent Claudication diagnosis, Intermittent Claudication epidemiology, Intermittent Claudication physiopathology, Ischemia diagnosis, Ischemia epidemiology, Ischemia physiopathology, Peripheral Arterial Disease diagnosis, Peripheral Arterial Disease epidemiology, Peripheral Arterial Disease physiopathology, Quality of Life, Recovery of Function, Treatment Outcome, United States epidemiology, American Heart Association, Exercise Therapy methods, Intermittent Claudication therapy, Ischemia therapy, Lower Extremity blood supply, Peripheral Arterial Disease therapy
- Published
- 2019
- Full Text
- View/download PDF
47. Variability in Individual Response to Aerobic Exercise Interventions Among Older Adults.
- Author
-
Whipple MO, Schorr EN, Talley KMC, Lindquist R, Bronas UG, and Treat-Jacobson D
- Subjects
- Age Factors, Aged, Body Mass Index, Female, Humans, Male, Racial Groups, Sex Factors, Exercise, Oxygen Consumption, Physical Fitness
- Abstract
Although a plethora of evidence supports the benefits of exercise among older adults, a majority of studies have emphasized group differences, while giving little, if any, attention to individual differences. Given the lack of data on variability in response, the present review examined how nonresponse to aerobic exercise has been defined in older adult populations and characteristics associated with nonresponse among older adults. The results of this review suggest that interindividual variability in response of maximal oxygen consumption to aerobic exercise interventions is prevalent among older adults (1.4-63.4%); age, sex, race, and body mass index may not be critical determinants of nonresponse; whereas health status, baseline fitness, and exercise dose appear important. Future intervention studies should evaluate and report the variability in individual response of older adults to exercise; investigators should develop programs that allow for modification of components to assist older adults in achieving optimal benefit from exercise programs.
- Published
- 2018
- Full Text
- View/download PDF
48. Correction to: Power of Peer Support to Change Health Behavior to Reduce Risks for Heart Disease and Stroke for African American Men in a Faith-Based Community.
- Author
-
Lee S, Schorr E, Hadidi NN, Kelley R, Treat-Jacobson D, and Lindquist R
- Abstract
An error in Fig. 1 in this article as originally published ("Theme 6: feelings of belonging and being care for" was missing the numeral "6") has been corrected. The original article has been corrected.
- Published
- 2018
- Full Text
- View/download PDF
49. Power of Peer Support to Change Health Behavior to Reduce Risks for Heart Disease and Stroke for African American Men in a Faith-Based Community.
- Author
-
Lee S, Schorr E, Hadidi NN, Kelley R, Treat-Jacobson D, and Lindquist R
- Subjects
- Access to Information, Adult, Aged, Aged, 80 and over, Humans, Male, Men, Middle Aged, Pilot Projects, Problem Solving, Psychological Distance, Qualitative Research, Black or African American, Health Behavior, Heart Diseases prevention & control, Peer Group, Religion, Risk Reduction Behavior, Social Support, Stroke prevention & control
- Abstract
Introduction: Peer support has powerful potential to improve outcomes in a program of health behavior change; yet, how peer support is perceived by participants, its role, and how it contributes to intervention efficacy is not known, especially among African Americans. The purpose of this study was to identify the subjectively perceived experience and potential contributions of peer support to the outcomes of a peer group behavioral intervention designed to change health behavior to reduce risks for heart disease and stroke in African American men in a faith-based community., Methods: A peer support group intervention was implemented to increase health knowledge and to improve health behaviors in line with the American Heart Association's Life Simple 7 domains (get active, control cholesterol, eat better, manage blood pressure, lose weight, reduce blood sugar, and stop smoking). Fourteen peer group sessions and eight follow-up interviews with program participants were recorded, transcribed, and analyzed., Results: Seven key themes emerged, including (1) enhancing access to health behavior information and resources, (2) practicing and applying problem-solving skills with group feedback and support, (3) discussing health behavior challenges and barriers, (4) sharing health behavior changes, (5) sharing perceived health outcome improvements and benefits, (6) feelings of belonging and being cared for, and (7) addressing health of family and community., Conclusion: Qualitative findings revealed a positive perception of peer support and greater understanding of potential reasons why it may be an effective strategy for African American men.
- Published
- 2018
- Full Text
- View/download PDF
50. Use of a Wearable Activity Monitor in a Home-Based Exercise Intervention for Peripheral Artery Disease-Reply.
- Author
-
McDermott MM, Spring B, and Treat-Jacobson D
- Subjects
- Exercise, Exercise Therapy, Humans, Monitoring, Physiologic, Wearable Electronic Devices, Intermittent Claudication, Peripheral Arterial Disease
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.